• English
    • Italiano (Italian)
Rome, Italy
  • Rome, Italy
  • Francavilla, Italy
  • Via Giulio Vincenzo Bona 133 00156 - Rome, Italy
  • +39 06 33076611
  • Via Nazionale Adriatica Nord 45/b, 66023 - Francavilla al Mare (CH), Italy
  • +39 085 492191
GADA
  • home
  • about
    • company overview
    • company history
    • management
    • our people
    • facilities
  • solutions
    • Distribution
      • Cardiovascular
      • Blood & Infusion Management
      • Intensive Care
    • Integrated Healthcare Services
  • partners
  • news
  • careers
  • contact
GADA
  • home
  • about
    • company overview
    • company history
    • management
    • our people
    • facilities
  • solutions
    • Distribution
      • Cardiovascular
      • Blood & Infusion Management
      • Intensive Care
    • Integrated Healthcare Services
  • partners
  • news
  • careers
  • contact
Email: customerservice@gadagroup.com
Tel: +39 06 33076611
Fax: +39 085 4911823
Via Giulio Vincenzo Bona 133
00156 - Rome, Italy
  • Impella 2.5: safe hemodynamic support in patients undergoing combined PCI and BAV

    • 04/04/2019
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular
    No Comments
    Abioomed_impella_AS_CAD_BAV
    The Journal of Invasive Cardiology (J INVASIVE CARDIOL 2019;31[3]:52-56) publishes a prospective, non-randomized study about the safety and efficacy of elective use of hemodynamic support by the Impella 2.5 (Abiomed) in patients undergoing combined high-risk percutaneous coronary intervention (PCI) and balloon aortic valvuloplasty (BAV), as a bridge to transcatheter aortic valve replacement. The study was
    read more
  • The impact of Neovasc Reducer on ischemic burden and myocardial perfusion: the JACC article

    • 04/02/2019
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular, News
    No Comments
    neovasc_jacc_articolo
    Neovasc, partner of GADA and leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that JACC Cardiovascular Interventions published a peer reviewed article on the impact of Neovasc Reducer on ischemic burden and myocardial perfusion.  
    read more
  • STEMI: a study published on Circulation confirms the efficiency of Impella CP on unloading the left ventricle

    • 18/01/2019
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular, News
    No Comments
    impella_circulation_stemi
    A new study published on Circulation (Circulation.2019;139:337–346. DOI: 10.1161/CIRCULATIONAHA.118.038269), the outcomes of which have been presented at the AHA congress by prof. Navin K. Kapur (Tufts Medical Center), confirms efficiency and safety of Abiomed Impella CP on unloading the left ventricle in patients presenting with anterior ST-segment elevation myocardial infarction (STEMI) without cardiogenic shock. Trial
    read more
  • New partnership between GADA Italia and Lifetech Scientific Corporation

    • 10/01/2019
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular, News
    No Comments
    Lifetech_partnership_GADA
    GADA Italia and Lifetech Scientific Corporation (LSC) have engaged with a long-time agreement for exclusive distribution over the whole national territory. LSC, established in 1999 in Shenzhen (People's Republic of China), is one of the most dynamic company in the development, production, and commercialization of minimally invasive interventional medical devices to treat cardiovascular diseases. Its
    read more
  • Neovasc Reducer™: clinical results in microvascular angina

    • 08/01/2019
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular, News
    No Comments
    reducer neovasc
    The Neovasc Reducer™ system is an implantable device, designed to create a permanent and controlled narrowing of the coronary sinus aimed at improving perfusion of ischemic regions in the myocardium in patients with reversible ischemic cardiomyopathy. The Reducer ™ is for use in patients, often defined "no options", who have refractory angina pectoris associated with
    read more
  • The European experience of ACURATE neo in bicuspid and tricuspid aortic valves

    • 17/12/2018
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular, News
    No Comments
    acurate_neo_eurointervention
    The magazine EuroIntervention (EuroIntervention 2018; Jaa-467 2018, doi: 10.4244/EIJ-D-18-00281) publishes encouraging results about safety and feasibility of traetment of bicuspid aortic valves with the TAVI aortic valve ACURATE neo (Boston Scientific). The outcomes have been collected by a multicenter retrospective and not randomized study about European experience of ACURATE neo in bicuspid (BAV) and tricuspid
    read more
  • Gada and Principia SGR announce a new partnership

    • 30/10/2018
    • Posted by: Massimo Delle Donne
    • Category: News
    No Comments
    news_principia

    Gada announces the entry of Principia, through the Principia III-Health fund, into the share capital. “In a context of growing competitiveness, this transaction reflects the value of our Group which, has steadily gained significant positions over the years in the distribution of medical devices and innovative services for Italian public and private hospitals“, commented Davide

    read more
  • VA ECMO-Impella Association: pulmonary flow improvement and effective left ventricular discharge

    • 24/09/2018
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular, News
    No Comments
    abiomed_impella_asajo_2
    Asaio Journal magazine publishes an article on the improvement of pulmonary arterial flow that the Abiomed Impella ventricular support contributes to generating in patients undergoing ECMO veno-arterial treatment (VA ECMO). Abiomed Impella Impella devices are devices for temporary ventricular support. The areas of application are both protection during high-risk percutaneous coronary interventional procedures (PCI), circulatory
    read more
  • 1-Year Outcomes of the using of the ACURATE neo transcatheter heart valve in 1,000 Patients

    • 13/09/2018
    • Posted by: Massimo Delle Donne
    • Category: Cardiovascular, News
    No Comments
    acurate neo savi tf
    The JACC-Cardiovascular Intervention published the 1-year outcomes of the perspective and multicentre SAVI-TF registry: in 25 European centers, 1000 patients are enrolled treated with transfemoral access by Boston Scientific's ACURATE neo valve (Logistic EuroSCORE II 6.6%). ACURATE neo ACURATE neo valve, composed of a self-expanding nitinol stent and porcine pericardial skirt, is designed in order
    read more
  • BIOTRAC, healthcare traceability solution, has its web page

    • 06/07/2018
    • Posted by: Massimo Delle Donne
    • Category: Blood and Infusion Management
    No Comments
    BIOTRAC
     BIOTRAC, the innovative solution for identification and traceability in the healthcare sector, has its web page. Developed by Gadamed, a GADA Group company, it uses RFID technology (acronym of Radio-Frequency IDentification), which through radio-frequency and the support of a "reader" is able to read, communicate and update the information stored in the “tag” memory of
    read more
  • 1
  • 2
  • 3
  • …
  • 5
  • News Index
  • Cardiovascular
  • Blood and Infusion Management
  • Intensive Care
  • Blog
*
  • Impella 2.5: safe hemodynamic support in patients undergoing combined PCI and BAV
  • The impact of Neovasc Reducer on ischemic burden and myocardial perfusion: the JACC article
  • STEMI: a study published on Circulation confirms the efficiency of Impella CP on unloading the left ventricle
GADA
A trusted source of innovative solutions. The GADA companies distribute Cardiovascular, Blood and Infusion Management, Critical and Intensive Care solutions from industry leaders and offer full suites of integrated healthcare services.

recent news

  • Impella 2.5: safe hemodynamic support in patients undergoing combined PCI and BAV
  • The impact of Neovasc Reducer on ischemic burden and myocardial perfusion: the JACC article

quick links

  • About
  • Solutions
  • News
  • Partners
  • Careers
  • Contact
  • Privacy Policy
Copyright © 2016-2019 GADA Spa - P.IVA 04414701005
This site uses cookies. By closing this banner, scrolling the page, clicking on a link or continuing to navigate in another manner, you consent to the use of cookies. Accept Read More.